Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Upslanted palpebral fissure, Anterior polar cataract, Seizure, and Low muscle tone (hypotonia) and others. 45 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Seizure, Hydrocephalus, Intellectual disability |
EBP encodes EBP cholestenol delta-isomerase (230 aa). Isomerase that catalyzes the conversion of Delta(8)-sterols to their corresponding Delta(7)-isomers a catalytic step in the postlanosterol biosynthesis of cholesterol Highest expression in Liver (96.7 TPM) and Adrenal Gland (90.1 TPM).
MEND syndrome is caused by mutations in the EBP gene on chromosome X.
The EBP protein participates in EBP isomerizes ZYMSTNL to LTHSOL, RUNX1, SPI1 (PU.1), GATA2, TAL1 (SCL), FLI1, and MYB bind the CEBPA promoter, and SPI1 (PU.1), CEBPA and DEK bind the promoter of the CSF3R (G-CSFR) gene pathways.
EBP is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
X-linked chondrodysplasia punctata 2 (CDPX2) is a skeletal dysplasia that also affects the skin and eyes. Specific diagnostic criteria for CDPX2 have not been published. Classic CDPX2 occurs almost exclusively in females. There are reports of affected males with an XXY karyotype or with somatic mosaicism who have clinical manifestations similar to affected females.
CDPX2 should be suspected in an individual with the following clinical findings:
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
No approved treatments are currently available for MEND syndrome. The disease remains an area of unmet medical need.
No published guidelines exist to establish the extent of disease or proper management in an individual with X-linked chondrodysplasia punctata 2 (CDPX2). The following recommendations are based on current literature and the authors' experience. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with CDPX2, the evaluations summarized (if they have not already been completed) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Chondrodysplasia Punctata 2, X-Linked
Table 6. Recommended Surveillance for Individuals with Chondrodysplasia Punctata 2, X-Linked
System/Concern |
|---|
No clinical trials have been registered for MEND syndrome.
4 publications have been identified in PubMed for MEND syndrome. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (25%), and Basic Science / Preclinical (25%).
Fu F (2026). [PMID: 41634881](https://pubmed.ncbi.nlm.nih.gov/41634881/). *Hum Genomics*. [Diagnostic / Biomarker]
Bibi H (2025). [PMID: 39754633](https://pubmed.ncbi.nlm.nih.gov/39754633/). *Mol Biol Rep*. [Case Report / Case Series]
Qiao F (2025). [PMID: 40386185](https://pubmed.ncbi.nlm.nih.gov/40386185/). *Appl Clin Genet*. [Case Report / Case Series]
Yang C (2025). [PMID: 39798734](https://pubmed.ncbi.nlm.nih.gov/39798734/). *Int J Biol Macromol*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Nov 4, 2026, 4:21 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about MEND syndrome
4 |
Overlapping toe, Long fingers, 2-3 toe syndactyly |
Eyes | 3 | Anterior polar cataract, Cataract, Macular hypoplasia |
Growth and development | 2 | Short stature, Failure to thrive |
Muscles | 2 | Low muscle tone (hypotonia), Axial hypotonia |
Skin | 2 | Redundant neck skin, Dry, scaly skin (ichthyosis) |
Heart and blood vessels | 1 | Aortic valve stenosis |
Head and neck | 1 | High palate |
Kidneys and urinary system | 1 | Crossed fused renal ectopia |
Bones and joints | 1 | Excessive outward curvature of the upper spine (kyphosis) |
Variability in females. At least 95% of individuals with X-linked chondrodysplasia punctata 2 (CDPX2) are female. The clinical phenotypes in heterozygous females are highly variable and depend on the pattern of X-chromosome inactivation in relevant tissues (i.e., percentage of active X chromosomes with the pathogenic variant) and other possible modifying factors. Phenotypes range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, such as adults with only cutaneous features, short stature, or no recognizable physical abnormalities.
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Null EBP variants are associated with a severe CDPX2 phenotype in females and result in intrauterine lethality in males (except in a mosaic state). Hypomorphic hemizygous EBP variants are associated with a milder MEND phenotype in males .
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
A few clinically unaffected females with molecularly confirmed CDPX2 have been reported . However, these females were ascertained from segregation testing, and phenotyping may not have been as comprehensive as in the proband. Some women have been so mildly affected that they were identified only after having had a child with more severe features in whom CDPX2 was diagnosed. Although these adult women have subtle findings, their findings are sufficient to consider them affected.
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Several disorders demonstrate features similar to those of X-linked chondrodysplasia punctata 2 (CDPX2) and/or manifest stippling on radiographs and various combinations of limb asymmetry, short stature, intellectual disability, cataracts, and skin changes. The key radiologic finding of chondrodysplasia punctata occurs in various metabolic disorders, skeletal dysplasias, chromosome abnormalities, and teratogenic exposures.
Genetic Disorders
Table 3.
Disorders and Genes of Interest in the Differential Diagnosis of Chondrodysplasia Punctata 2, X-Linked
Differential Diagnosis Disorder | Gene(s) | MOI | Features of the Differential Diagnosis Disorder
Overlapping w/CDPX2 | Distinguishing from CDPX2
Skeletal dysplasia w/radiographic evidence of CDP1
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Genetic testing for EBP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for MEND syndrome has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Musculoskeletal | Orthopedic evaluation; full skeletal survey | To assess limb length differences, kyphoscoliosis, other skeletal abnormalities |
Respiratory | Pulmonary evaluation | In individuals w/severe scoliosis that compromises respiratory function |
Integument | Dermatology evaluation | — |
Eyes | Ophthalmologic evaluation | To evaluate for congenital cataracts other ocular abnormalities |
Hearing | Hearing evaluation | To evaluate for hearing loss |
Renal | Renal ultrasound examination | To identify monitor hydronephrosis |
Other | Consultation w/clinical geneticist /or genetic counselor | To incl genetic counseling Treatment of Manifestations Treatment is symptomatic and should be tailored to the individual. Table 5. |
Treatment of Manifestations in Individuals with Chondrodysplasia Punctata 2, X-Linked Manifestation/Concern | Treatment | Considerations/Other Skeletal |
manifestations | Treatment per orthopedist | Scoliosis can progress rapidly. Initial surgery may have a high rate of failure require revision or more invasive treatments . Respiratory |
compromise | Management per pulmonologist | — |
Skin lesions | Dermatologic management w/emollients keratolytics | Sun protection for those w/ichthyosis; emollient use can increase risk of sunburn. Ocular anomalies |
Recommended Surveillance for Individuals with Chondrodysplasia Punctata 2, X-Linked System/Concern | Evaluation | Frequency |
Musculoskeletal | Orthopedic evaluation | Frequency per orthopedist to monitor kyphoscoliosis or joint problems assess linear growth any leg length discrepancy; Scoliosis can progress rapidly. |
Integument | Dermatology evaluation | Frequency per dermatologist |
Eyes | Ophthalmology evaluation | Frequency per ophthalmologist |
Hearing | Audiology evaluation | As clinically indicated |
Renal | Renal ultrasound | Frequency per nephrologist to monitor hydronephrosis if present Miscellaneous/ |
Other | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination. | Each visit Adequate sun protection is recommended for individuals with ichthyosis, who are at risk of dehydration secondary to overheating during prolonged sun exposure. Furthermore, care must be taken with use of emollients (which are oil based) and direct sun exposure, which can lead to sunburn. |
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Adequate sun protection is recommended for individuals with ichthyosis, who are at risk of dehydration secondary to overheating during prolonged sun exposure. Furthermore, care must be taken with use of emollients (which are oil based) and direct sun exposure, which can lead to sunburn.
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
View trials for MEND syndrome
Evaluation
Frequency |
|---|
Musculoskeletal | Orthopedic evaluation | Frequency per orthopedist to monitor kyphoscoliosis or joint problems assess linear growth any leg length discrepancy; Scoliosis can progress rapidly. |
Integument | Dermatology evaluation | Frequency per dermatologist |
Eyes | Ophthalmology evaluation | Frequency per ophthalmologist |
Hearing | Audiology evaluation | As clinically indicated |
Renal | Renal ultrasound | Frequency per nephrologist to monitor hydronephrosis if present Miscellaneous/ |
Other | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) care coordination. | Each visit |
Source: GeneReviews — "Chondrodysplasia Punctata 2, X-Linked"
Phenotype severity distribution: 30 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).